Dry-Powder Inhalation Capsule Portfolio

Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication.

Capsugel® Zephyr™ is Lonza’s customizable dry-powder inhalation capsule portfolio that is optimized to provide superior performance and compatibility between the capsule/device and capsule/formulation.

Our dry-powder inhalation capsule portfolio offers:

  • Consistent powder release
  • A customized approach to optimize performance of the end product
  • Compatibility with a large selection of device principles and opening systems
  • Ideal puncturing and cutting performance

Download the fact sheet to learn more.

Capsugel® Zephyr Dry-Powder Inhalation Portfolio